Details for Patent: RE46617
Which drugs does patent RE46617 protect, and when does it expire?
Patent RE46617 protects BAXDELA and is included in two NDAs.
This patent has forty-three patent family members in twenty-six countries.
Summary for Patent: RE46617
| Title: | Process for making quinolone compounds |
| Abstract: | The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced. |
| Inventor(s): | Roger Hanselmann, Maxwell M. Reeve, Graham Johnson |
| Assignee: | Melinta Subsidiary Corp |
| Application Number: | US14/743,365 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; |
Drugs Protected by US Patent RE46617
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Melinta | BAXDELA | delafloxacin meglumine | POWDER;INTRAVENOUS | 208611-001 | Jun 19, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Melinta | BAXDELA | delafloxacin meglumine | TABLET;ORAL | 208610-001 | Jun 19, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46617
| PCT Information | |||
| PCT Filed | September 23, 2009 | PCT Application Number: | PCT/US2009/005276 |
| PCT Publication Date: | April 01, 2010 | PCT Publication Number: | WO2010/036329 |
International Family Members for US Patent RE46617
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3214083 | ⤷ Start Trial | 301091 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3214083 | ⤷ Start Trial | 122021000010 | Germany | ⤷ Start Trial |
| European Patent Office | 3214083 | ⤷ Start Trial | 132021000000011 | Italy | ⤷ Start Trial |
| European Patent Office | 3214083 | ⤷ Start Trial | LUC00196 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 3214083 | ⤷ Start Trial | PA2021002 | Lithuania | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
